Fevertree Drinks announces David Lapp to join its Board as Non-Executive Director

– UK, London –  Fevertree Drinks plc (LON: FEVR), the world’s leading supplier of premium carbonated mixers, today announced the appointment of David Lapp to its Board as a Non-Executive Director, effective from 1 January 2024.

About David Lapp

David Lapp brings over 35 years of extensive industry expertise in the beverage sector including bottling, manufacturing, supply chain management, and strategy across the North American and European markets. David served as Senior Vice President and Chief Supply Chain Officer for PepsiCo Beverages North America where he was accountable for leading the end-to-end supply chain operations for PBNA. Most recently he was Senior Vice President of Manufacturing Strategy across food and beverages for PepsiCo’s North American business. Before these roles, he served 22 years at Pepsi Bottling Group across the business’ manufacturing and warehouse operations – culminating in the role of Global VP of Manufacturing and Warehouse Operations – before joining PepsiCo when it acquired the business in 2010.

About Fever-Tree

Fever-Tree is the world’s leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 85 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high-quality mixers that could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum, and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars, and cafes as well as selected retail outlets.

For more information: https://fever-tree.com/en_GB

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.